Ability of known colorectal cancer susceptibility SNPs to predict colorectal cancer risk: A cohort study within the UK Biobank.

Colorectal cancer risk stratification is crucial to improve screening and risk-reducing recommendations, and consequently do better than a one-size-fits-all screening regimen. Current screening guidelines in the UK, USA and Australia focus solely on family history and age for risk prediction, even t...

Full description

Bibliographic Details
Main Authors: Aviv Gafni, Gillian S Dite, Erika Spaeth Tuff, Richard Allman, John L Hopper
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0251469
_version_ 1811295477472165888
author Aviv Gafni
Gillian S Dite
Erika Spaeth Tuff
Richard Allman
John L Hopper
author_facet Aviv Gafni
Gillian S Dite
Erika Spaeth Tuff
Richard Allman
John L Hopper
author_sort Aviv Gafni
collection DOAJ
description Colorectal cancer risk stratification is crucial to improve screening and risk-reducing recommendations, and consequently do better than a one-size-fits-all screening regimen. Current screening guidelines in the UK, USA and Australia focus solely on family history and age for risk prediction, even though the vast majority of the population do not have any family history. We investigated adding a polygenic risk score based on 45 single-nucleotide polymorphisms to a family history model (combined model) to quantify how it improves the stratification and discriminatory performance of 10-year risk and full lifetime risk using a prospective population-based cohort within the UK Biobank. For both 10-year and full lifetime risk, the combined model had a wider risk distribution compared with family history alone, resulting in improved risk stratification of nearly 2-fold between the top and bottom risk quintiles of the full lifetime risk model. Importantly, the combined model can identify people (n = 72,019) who do not have family history of colorectal cancer but have a predicted risk that is equivalent to having at least one affected first-degree relative (n = 44,950). We also confirmed previous findings by showing that the combined full lifetime risk model significantly improves discriminatory accuracy compared with a simple family history model 0.673 (95% CI 0.664-0.682) versus 0.666 (95% CI 0.657-0.675), p = 0.0065. Therefore, a combined polygenic risk score and first-degree family history model could be used to improve risk stratified population screening programs.
first_indexed 2024-04-13T05:33:12Z
format Article
id doaj.art-788e69b5d3f84bf098ab266ef4cf3d72
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-13T05:33:12Z
publishDate 2021-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-788e69b5d3f84bf098ab266ef4cf3d722022-12-22T03:00:22ZengPublic Library of Science (PLoS)PLoS ONE1932-62032021-01-01169e025146910.1371/journal.pone.0251469Ability of known colorectal cancer susceptibility SNPs to predict colorectal cancer risk: A cohort study within the UK Biobank.Aviv GafniGillian S DiteErika Spaeth TuffRichard AllmanJohn L HopperColorectal cancer risk stratification is crucial to improve screening and risk-reducing recommendations, and consequently do better than a one-size-fits-all screening regimen. Current screening guidelines in the UK, USA and Australia focus solely on family history and age for risk prediction, even though the vast majority of the population do not have any family history. We investigated adding a polygenic risk score based on 45 single-nucleotide polymorphisms to a family history model (combined model) to quantify how it improves the stratification and discriminatory performance of 10-year risk and full lifetime risk using a prospective population-based cohort within the UK Biobank. For both 10-year and full lifetime risk, the combined model had a wider risk distribution compared with family history alone, resulting in improved risk stratification of nearly 2-fold between the top and bottom risk quintiles of the full lifetime risk model. Importantly, the combined model can identify people (n = 72,019) who do not have family history of colorectal cancer but have a predicted risk that is equivalent to having at least one affected first-degree relative (n = 44,950). We also confirmed previous findings by showing that the combined full lifetime risk model significantly improves discriminatory accuracy compared with a simple family history model 0.673 (95% CI 0.664-0.682) versus 0.666 (95% CI 0.657-0.675), p = 0.0065. Therefore, a combined polygenic risk score and first-degree family history model could be used to improve risk stratified population screening programs.https://doi.org/10.1371/journal.pone.0251469
spellingShingle Aviv Gafni
Gillian S Dite
Erika Spaeth Tuff
Richard Allman
John L Hopper
Ability of known colorectal cancer susceptibility SNPs to predict colorectal cancer risk: A cohort study within the UK Biobank.
PLoS ONE
title Ability of known colorectal cancer susceptibility SNPs to predict colorectal cancer risk: A cohort study within the UK Biobank.
title_full Ability of known colorectal cancer susceptibility SNPs to predict colorectal cancer risk: A cohort study within the UK Biobank.
title_fullStr Ability of known colorectal cancer susceptibility SNPs to predict colorectal cancer risk: A cohort study within the UK Biobank.
title_full_unstemmed Ability of known colorectal cancer susceptibility SNPs to predict colorectal cancer risk: A cohort study within the UK Biobank.
title_short Ability of known colorectal cancer susceptibility SNPs to predict colorectal cancer risk: A cohort study within the UK Biobank.
title_sort ability of known colorectal cancer susceptibility snps to predict colorectal cancer risk a cohort study within the uk biobank
url https://doi.org/10.1371/journal.pone.0251469
work_keys_str_mv AT avivgafni abilityofknowncolorectalcancersusceptibilitysnpstopredictcolorectalcancerriskacohortstudywithintheukbiobank
AT gilliansdite abilityofknowncolorectalcancersusceptibilitysnpstopredictcolorectalcancerriskacohortstudywithintheukbiobank
AT erikaspaethtuff abilityofknowncolorectalcancersusceptibilitysnpstopredictcolorectalcancerriskacohortstudywithintheukbiobank
AT richardallman abilityofknowncolorectalcancersusceptibilitysnpstopredictcolorectalcancerriskacohortstudywithintheukbiobank
AT johnlhopper abilityofknowncolorectalcancersusceptibilitysnpstopredictcolorectalcancerriskacohortstudywithintheukbiobank